Castle Biosciences Closes $11.7M Tranche of $20M Series F Financing

July 27, 2015 @ 10:16 am By Samantha Hurst |

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced it has closed the first tranche of a $20 million Series F financing, raising $11.7 million. The funding will be used to accelerate the growth in clinical adoption of Castle… Read More

Twitter
Facebook
LinkedIn
Pinterest
Reddit
HackerNews
Telegram
Weibo
Email
Print
Subscribe

Read more in: General News, Offerings | Tagged cancer, castle biosciences, derek maetzold, diagnostics, industry ventures, molecular, series f, treatment, victor hwang